ArticleFrontiers in oncology2022

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience.

Sabah Alaklabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.